Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
41M
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
101K
-
Shares change
-
-2.7K
-
Total reported value, excl. options
-
$1.86M
-
Value change
-
-$49.6K
-
Number of buys
-
2
-
Number of sells
-
-5
-
Price
-
$18.45
Significant Holders of ArriVent BioPharma, Inc. - Common Stock (AVBP) as of Q3 2025
8 filings reported holding AVBP - ArriVent BioPharma, Inc. - Common Stock as of Q3 2025.
ArriVent BioPharma, Inc. - Common Stock (AVBP) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 101K shares
of 41M outstanding shares and own 0.25% of the company stock.
Largest 8 shareholders include Moody Aldrich Partners LLC (59.5K shares), SG Americas Securities, LLC (36.9K shares), KLP KAPITALFORVALTNING AS (3.1K shares), SIGNATUREFD, LLC (368 shares), NISA INVESTMENT ADVISORS, LLC (313 shares), CWM, LLC (281 shares), Versant Capital Management, Inc (190 shares), and GAMMA Investing LLC (85 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.